{Reference Type}: Randomized Controlled Trial
{Title}: Randomized controlled trial of omalizumab in treatment-resistant systemic and cutaneous mastocytosis (ROAM).
{Author}: McComish JS;Slade CA;Buizen L;Paul SK;Chatelier JW;Unglik G;Nicholls KA;Spriggs K;Chan SS;Godsell J;Auyeung P;Tan ZH;DeLuca J;Patel M;Kuek LE;Tran Y;Kern JS;Scardamaglia L;Varigos GA;Juneja S;Grabek JA;Christie M;Mackay GA;Douglass JA;
{Journal}: J Allergy Clin Immunol Pract
{Volume}: 11
{Issue}: 7
{Year}: 2023 07 23
暂无{DOI}: 10.1016/j.jaip.2023.04.008